|
|
清咳平喘颗粒治疗呼吸系统疾病的相关研究进展
|
Abstract:
清咳平喘颗粒是中医临床诊治呼吸系统疾病的经典方剂，具有应用广泛，疗效显著的特点。目前实验研究表明清咳平喘颗粒具有增强免疫、减轻肺损伤、抗病毒等多种作用，用于治疗呼吸系统诸多疾病，例如社区获得性肺炎、支气管哮喘、慢性阻塞性肺病、急性支气管炎等。大量的临床研究也表明清咳平喘颗粒具有改善症状、提高疗效、治疗显著、不良反应少、便捷方便等优点。本文旨在总结归纳近年来关于清咳平喘颗粒的实验研究、药理作用及临床运用。
Qingke Pingchuan Granules are a classic prescription in traditional Chinese medicine for the clinical diagnosis and treatment of respiratory diseases, characterized by wide application and remarkable efficacy. Current experimental studies have shown that Qingke Pingchuan Granules have multiple effects, such as enhancing immunity, alleviating lung injury, and combating viruses, and are used to treat various respiratory diseases, including community-acquired pneumonia, bronchial asthma, chronic obstructive pulmonary disease, and acute bronchitis. A large number of clinical studies have also indicated that Qingke Pingchuan Granules have advantages such as symptom improvement, enhanced therapeutic efficacy, significant treatment results, few adverse reactions, and convenience. This paper aims to summarize the experimental research, pharmacological effects, and clinical applications of Qingke Pingchuan Granules in recent years.
| [1] | Wu, Y., Zhu, W., Rouzi, A., Tong, L., Han, L., Song, J., et al. (2022) The Traditional Chinese Patented Medicine Qingke Pingchuan Granules Alleviate Acute Lung Injury by Regenerating Club Cells. Pulmonary Circulation, 12, e12138. https://doi.org/10.1002/pul2.12138 |
| [2] | He, L., Cao, J., Xie, X., Zhang, Y., Zhang, X., Wang, H., et al. (2024) Effects and Mechanism of Qingke Pingchuan Granules against Influenza Virus Infection. Archives of Virology, 169, Article No. 130. https://doi.org/10.1007/s00705-024-06053-z |
| [3] | Cheng, M., Yan, X., Wu, Y., Zeng, Z., Zhang, Y., Wen, F., et al. (2025) Qingke Pingchuan Granules Alleviate Airway Inflammation in COPD Exacerbation by Inhibiting Neutrophil Extracellular Traps in Mice. Phytomedicine, 136, Article ID: 156283. https://doi.org/10.1016/j.phymed.2024.156283 |
| [4] | 田楠楠, 杨茜和, 朱雅暄, 等. 麻黄的化学成分及其药效作用和药代特征[J]. 中国中药杂志, 2022, 47(13): 3409-3424. |
| [5] | 李竹英, 陈璐, 王丽洁. 麻黄-白果药对“异病同治”支气管哮喘和慢性阻塞性肺疾病药理作用研究[J]. 陕西中医, 2021, 42(8): 1128-1132. |
| [6] | 马青, 龚轩. 由“石膏微溶而重用之”引发的三条术数猜想[J]. 医学争鸣, 2018, 9(5): 23. |
| [7] | 王陶陶, 杨德林, 韩娜, 等. 中药石膏药理作用研究进展与其清热物质基础探讨[J]. 中国中药杂志, 2024, 49(4): 853-857. |
| [8] | 钟昌会, 钱进, 杨远征, 等. 苦杏仁苷对支气管哮喘大鼠Kelch样环氧氯丙烷相关蛋白-1/核因子E2相关因子2信号通路的影响[J]. 中国临床药理学杂志, 2022, 38(18): 2157-2161. |
| [9] | Hu, Y., Liu, X., Song, Y., Zhang, Y., Li, W., Zhang, L., et al. (2024) Exploring the Anti‐Inflammatory Ingredients and Potential of Golden Buckwheat (Fagopyrum dibotrys) on the TLR4/NLRP3 Pathway in Acute Lung Injury. Food Science & Nutrition, 12, 5426-5441. https://doi.org/10.1002/fsn3.4193 |
| [10] | Wang, X., Jiao, Y., Zhu, H., Lu, Y. and Chen, D. (2023) Exploring the Anticomplement Components from Fagopyrum dibotrys for the Treatment of H1N1-Induced Acute Lung Injury by UPLC-Triple-TOF-MS/MS. Journal of Pharmaceutical and Biomedical Analysis, 223, Article ID: 115158. https://doi.org/10.1016/j.jpba.2022.115158 |
| [11] | He, X., Hu, M., Song, C., Ni, M., Liu, L., Chen, C., et al. (2023) Sodium New Houttuyfonate Effectively Improves Phagocytosis and Inhibits the Excessive Release of Inflammatory Factors by Repressing TLR4/Nf-κB Pathway in Macrophages. Current Pharmaceutical Biotechnology, 24, 1964-1971. https://doi.org/10.2174/1389201024666230418163100 |
| [12] | 刘苗苗, 崔清华, 范路路, 等. 鱼腥草多糖的制备及其体外抗病毒活性研究[J]. 天然产物研究与开发, 2020, 32(1): 110-117. |
| [13] | Ling, T., Xie, J., Shen, Y.S., et al. (2020) Trichostatin A Exerts Anti-Inflammation Functions in LPS-Induced Acute Lung Injury Model through Inhibiting TNF-α and Upregulating micorRNA-146a Expression. European Review for Medical and Pharmacological Sciences, 24, 3935-3942. |
| [14] | Cao, G.X., Li, R.R., Liu, J., et al. (2016) Β-Caryophyllene Protects Cerebral Cortical Neurons against Cerebral Ischemia and Reperfusion in Rats by Improving Antioxidant Activities. Pharmacology and Clinics of Chinese Materia Medica, 32, 56-60. |
| [15] | Zhou, C.L. and Qian, Z.Y. (2006) Inhibitory Effect of β-Caryophyllenol on Airway Inflammation and Elimination OFR of Asthmatic Models in Guinea Pigs. Pharmaceutical Biotechnology, 13, 373-376. |
| [16] | 陈宝磊, 高映春, 吴磊. 枇杷叶提取物通过激活磷脂酰肌醇3激酶/蛋白激酶B信号通路减轻脂多糖诱导的肺细胞损伤[J]. 安徽医药, 2022, 26(3): 453-457. |
| [17] | 邵宏华, 朱亮, 陈巧巧. 基于HMGB1/TLR4/NF-κB信号通路研究枇杷叶提取物对急性肺损伤模型大鼠炎症因子的影响[J]. 浙江中西医结合杂志, 2024, 34(9): 803-809. |
| [18] | Ma, P.N. (2015) Pharmacological Studies on the Antitussive, Expectorant and Asthmatic Effects of Perilla Seeds. China Practical Medical, 10, 159-160. |
| [19] | Yin, H.P., et al. (2007) Effect of Perilla frutescens Seed Oil on Eosinophils Inhibition in Asthmatic Model Mice. Health & Research, 27, 212-214. |
| [20] | Xu, G., Fu, S., Zhan, X., Wang, Z., Zhang, P., Shi, W., et al. (2021) Echinatin Effectively Protects against NLRP3 Inflammasome-Driven Diseases by Targeting HSP90. JCI Insight, 6, e134601. https://doi.org/10.1172/jci.insight.134601 |
| [21] | 徐雅莉. 甘草水炙炮制工艺及药性初步研究[D]: [硕士学位论文]. 成都: 西南民族大学, 2020. |
| [22] | 严廷巍, 吕华. 蒿芩清胆汤治疗社区获得性肺炎(湿热内郁型)的疗效及对血清炎症因子、血气指标的影响[J]. 四川中医, 2021, 39(5): 81-84. |
| [23] | 狄浩然, 傅梦清, 辛大永. 清咳平喘颗粒治疗社区获得性肺炎痰热壅肺证的临床疗效观察[J]. 中草药, 2022, 53(19): 6117-6122. |
| [24] | 任明霞, 赵皖京. 清咳平喘颗粒联合莫西沙星治疗成人轻中度社区获得性肺炎临床观察[J]. 中草药, 2022, 53(11): 3410-3414. |
| [25] | 金少涵, 朱梦婷, 罗胜, 等. 清咳平喘颗粒联合西医常规治疗成人社区获得性肺炎痰热壅肺证的多中心随机对照研究[J]. 中草药, 2024, 55(12): 4099-4107. |
| [26] | 于向艳, 闫红倩, 宿英豪, 等. 清咳平喘颗粒治疗慢性阻塞性肺疾病急性加重(痰热郁肺证)的临床疗效及对血清IL-6、PCT的影响[J]. 中草药, 2024, 55(11): 3768-3773. |
| [27] | 张志杰, 崔红生, 黄贵锐, 等. 清咳平喘颗粒治疗慢阻肺急性加重期痰热郁肺证的临床观察[J]. 中国实验方剂学杂志, 2024, 30(16): 85-91. |
| [28] | 任韶聪, 范斐婷, 肖晶, 等. 清咳平喘颗粒治疗慢性阻塞性肺疾病急性加重期痰热壅肺证的临床研究[J]. 中草药, 2023, 54(19): 6377-6385. |
| [29] | 张永法, 张海军, 蔺萃. 清咳平喘颗粒联合雾化吸入对儿童热性哮喘急性发作的临床效果及对肺功能、呼气一氧化氮的影响[J]. 医学理论与实践, 2021, 34(1): 111-113. |
| [30] | 李慧娇, 王一萍, 何薇, 等. 清咳平喘颗粒配合常规西药治疗咳嗽变异性哮喘疗效观察及对血清ICAM-1、Eotaxin水平的影响[J]. 新中医, 2022, 54(10): 61-65. |
| [31] | 东雪洁, 贾广媛, 张葆青, 等. 清咳平喘颗粒联合布地奈德和硫酸特布他林治疗小儿支气管哮喘急性发作期(热哮证)的疗效观察[J]. 现代药物与临床, 2023, 38(5): 1142-1146. |
| [32] | Rybka-Fraczek, A., Dabrowska, M., Grabczak, E.M., Bialek-Gosk, K., Klimowicz, K., Truba, O., et al. (2022) Inflammatory Phenotypes of Cough Variant Asthma as Response Predictors to Anti-Asthmatic Therapy. Journal of Inflammation Research, 15, 595-602. https://doi.org/10.2147/jir.s343411 |
| [33] | Xu, Q., Lu, T., Song, Z., Zhu, P., Wu, Y., Zhang, L., et al. (2023) Efficacy and Safety of Montelukast Adjuvant Therapy in Adults with Cough Variant Asthma: A Systematic Review and Meta‐Analysis. The Clinical Respiratory Journal, 17, 986-997. https://doi.org/10.1111/crj.13629 |
| [34] | 龚峰, 张莉, 周莉. 清咳平喘颗粒联合丙酸氟替卡松治疗儿童咳嗽变异性哮喘的临床研究[J]. 现代药物与临床, 2024, 39(9): 2338-2342. |
| [35] | 周志伟, 黄鹏展, 邱海丽. 清咳平喘颗粒联合沙美特罗替卡松治疗热伤肺络型咳嗽变异性哮喘的临床研究[J]. 现代药物与临床, 2022, 37(6): 1338-1342. |
